These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.
    Author: Knowles SR, Phillips EJ, Dresser L, Matukas L.
    Journal: Clin Infect Dis; 2003 Oct 15; 37(8):1139-42. PubMed ID: 14523782.
    Abstract:
    Although information on efficacy and adverse drug reactions is lacking, ribavirin has been used empirically for the treatment of severe acute respiratory syndrome (SARS). We report common adverse events in 110 patients with suspected or probable SARS who were treated with ribavirin. Sixty-one percent of the patients had evidence of hemolytic anemia, and hypocalcemia and hypomagnesmia were reported in 58% and 46% of patients, respectively.
    [Abstract] [Full Text] [Related] [New Search]